685 US HIGHWAY ONE, NORTH BRUNSWICK, NJ
Annual Report to Security Holders
Financial Restatement Due to Misapplication of ASC 820
Announces Second Quarter 2026 Financial Results
Investor Presentation
Pelthos Therapeutics Dismisses CBIZ as Independent Auditor
Announces First Quarter 2026 Financial Results
Reg. FD
Announces CFO Transition
Q2
Amended Quarterly Report
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload
Definitive Merger Information Statement